Results 191 to 200 of about 128,678 (309)

Social survey on knowledge, attitude and practice of hypertrophic cardiomyopathy. [PDF]

Front Cardiovasc Med
Lan W, He B, Hu S.
europepmc   +1 more source

Personalized Arrhythmic Risk Stratification for Sudden Cardiac Death in Ischemic, Non-ischemic, and Hypertrophic Cardiomyopathy Patients: The Two-Step, Non-invasive Risk Factors Guiding to Electrophysiology Study Approach

, 2023
Πέτρος Αρσένος, Athanasios Kordalis, Polychronis Dilaveris, Ioannis Doundoulakis, C. Antoniou, Ageliki Laina, Nikias Milaras, Anastasia Xintarakou, Dimitris Tsiachris, Skevos Sideris, Konstantinos Toutouzas, Konstantinos Tsioufis, Konstantinos Gatzoulis   +12 more
openalex   +2 more sources

Rationale and Design of the Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure

Clinical Cardiology, Volume 49, Issue 2, February 2026.
The COPILOT‐HF trial is a pragmatic, randomized study designed to determine if a remote, pharmacist‐led navigator‐driven intervention with patient and provider education is more effective than patient and provider education alone at improving the implementation of guideline‐directed medical therapy for patients across the full spectrum of heart failure.
Alexander J. Blood, Ozan Unlu, John W. Ostrominski, Shahzad Hassan, Hunter Nichols, Samantha Subramaniam, Daniel Gabovitch, Jacqueline Chasse, Marian McPartlin, Christian Figueroa, Emma Collins, Megan Twining, Matthew Varugheese, Kavishwar Wagholikar, Christopher P. Cannon, Akshay S. Desai, Benjamin M. Scirica   +16 more
wiley   +1 more source

[Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].

Archivos de cardiologia de Mexico, 2003
Hypertrophic cardiomyopathy is a relatively common genetic disorder with heterogeneity in mutations, forms of presentation, prognosis and treatment strategies. Hypertrophic cardiomyopathy is recognized as the most common cause of sudden cardiac death that occurs in young people, including athletes.
openaire   +1 more source

INFECTIVE ENDOCARDITIS DUE TO GEMELLA-MORBILLORUM COMPLICATING HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [PDF]

, 1994
Campbell, NP, Kerr, JR, McGimpsey, JG, Webb, CH   +3 more
core   +1 more source

High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression

Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.
The first discovery of miR5700 in tumour progression: 1. Atypical type A thymoma was the most invasive and metastatic subtype of thymic epithelial tumour, and difficult to diagnose in pathology owing to the scarcity of specific biomarkers and well‐defined molecular targets. 2. miR‐5700 was markedly overexpressed in atypical type A thymoma. 3.
Li Zhao, Yi‐Yang Chen, Li‐Yang Li, Yun‐Lan Tao, Gang Chen   +4 more
wiley   +1 more source

Genetic Testing For Hypertrophic Cardiomyopathy

, 2008
Ali J. Marian
openalex   +1 more source

P1489Sustained long term benefits after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a single centre experience [PDF]

, 2018
Daniel A. Leung, PK Cheung, M Cheuk, M. Dorsch, Amy Jones   +4 more
openalex   +1 more source

Heyde Syndrome: A Literature Review

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement.
Yashika Gupta, Abdul Rehman Shahid Khan, Viraj Shetty, Yeshwini Murali Krishna, Ayisha Maqsood, Muhammad Husnain Ahmad, Masab Ali, Betsy Samuel, Ali Gohar, Abdul Waheed, Muhammad Bilal Afzal, Rehan Naseer Ahmad, Saqib Maqsood   +12 more
wiley   +1 more source

A New Era in the Management of Hypertrophic Cardiomyopathy. [PDF]

Rev Cardiovasc Med
Perez-Asensio A, Llamas-Gomez H, Lara-Palomo A, Villar-Ruiz A, Jimenez-Mendez C, Palomino-Doza J.   +5 more
europepmc   +1 more source